1 – 10 of 114
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Initial surveillance in men with marker negative clinical stage IIA non-seminomatous germ cell tumours
(
- Contribution to journal › Article
-
Mark
An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancer
(
- Contribution to journal › Article
-
Mark
Biliary tract cancer
2024) In European Journal of Surgical Oncology(
- Contribution to journal › Article
- 2023
-
Mark
Priorities in Cardio-Oncology Basic and Translational Science : GCOS 2023 Symposium Proceedings: JACC: CardioOncology State-of-the-Art Review
(
- Contribution to journal › Scientific review
-
Mark
Clinical insights into small cell lung cancer : Tumor heterogeneity, diagnosis, therapy, and future directions
(
- Contribution to journal › Scientific review
-
Mark
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma : 2023 Update
(
- Contribution to journal › Scientific review
-
Mark
Biomarkers or biotargets? Using competition to lure cancer cells into evolutionary traps
(
- Contribution to journal › Article
-
Mark
Real-world analysis of MET exon 14 mutations in non-small cell lung cancer : a retrospective study from two Swedish hospitals
(
- Contribution to journal › Article
- 2022
-
Mark
Molecular Subtypes as a Basis for Stratified Use of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer—A Narrative Review
(
- Contribution to journal › Scientific review
-
Mark
Testicular Dysfunction Among Cancer Survivors
(
- Contribution to journal › Scientific review